{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T23:03:16Z","timestamp":1770073396512,"version":"3.49.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T00:00:00Z","timestamp":1729123200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T00:00:00Z","timestamp":1729123200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"DOI":"10.1007\/s12032-024-02532-0","type":"journal-article","created":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T15:03:08Z","timestamp":1729177388000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Personalized oncology in pheochromocytomas and paragangliomas: integrating genetic analysis with machine learning"],"prefix":"10.1007","volume":"41","author":[{"family":"Abida","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdullah R.","family":"Alzahrani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hayaa M.","family":"Alhuthali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Afnan","family":"Alkathiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruba Omar M.","family":"Almaghrabi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jawaher Mohammad","family":"Alshehri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syed Mohammed Basheeruddin","family":"Asdaq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohd","family":"Imran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,10,17]]},"reference":[{"key":"2532_CR1","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1097\/PPO.0000000000000723","volume":"30","author":"N Mallak","year":"2024","unstructured":"Mallak N, O\u2019Brien SR, Pryma DA, Mittra E. Theranostics in neuroendocrine tumors. Cancer J. 2024;30:185.","journal-title":"Cancer J"},{"key":"2532_CR2","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1002\/cncr.29099","volume":"121","author":"J Hallet","year":"2015","unstructured":"Hallet J, Law CHL, Cukier M, Saskin R, Liu N, Singh S. Exploring the rising incidence of neuroendocrine tumors: a population-based analysis of epidemiology, metastatic presentation, and outcomes. Cancer. 2015;121:589\u201397.","journal-title":"Cancer"},{"key":"2532_CR3","doi-asserted-by":"publisher","first-page":"e435","DOI":"10.1016\/S1470-2045(15)00186-2","volume":"16","author":"K Oberg","year":"2015","unstructured":"Oberg K, Modlin IM, De Herder W, Pavel M, Klimstra D, Frilling A, et al. Consensus on biomarkers for neuroendocrine tumour disease. Lancet Oncol. 2015;16:e435\u201346.","journal-title":"Lancet Oncol"},{"key":"2532_CR4","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1586\/egh.12.15","volume":"6","author":"S Singh","year":"2012","unstructured":"Singh S, Law C. Chromogranin A: a sensitive biomarker for the detection and post-treatment monitoring of gastroenteropancreatic neuroendocrine tumors. Expert Rev Gastroenterol Hepatol. 2012;6:313\u201334.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"2532_CR5","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.bpg.2005.06.003","volume":"19","author":"B Stinner","year":"2005","unstructured":"Stinner B, Rothmund M. Neuroendocrine tumors (carcinoids) of the appendix. Best Pract Res Clin Gastroenterol. 2005;19:729\u201338.","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"2532_CR6","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1159\/000481390","volume":"33","author":"G Kl\u00f6ppel","year":"2017","unstructured":"Kl\u00f6ppel G. Neuroendocrine neoplasms: dichotomy, origin and classifications. Visc Med. 2017;33:324\u201330.","journal-title":"Visc Med"},{"key":"2532_CR7","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1053\/j.seminoncol.2010.10.015","volume":"37","author":"JA Carrasquillo","year":"2010","unstructured":"Carrasquillo JA, Chen CC. Molecular imaging of neuroendocrine tumors. Semin Oncol. 2010;37:662\u201379.","journal-title":"Semin Oncol"},{"issue":"2","key":"2532_CR8","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/nrc3648","volume":"14","author":"PLM Dahia","year":"2014","unstructured":"Dahia PLM. Pheochromocytoma and paraganglioma pathogenesis: learning from genetic heterogeneity. Nature Rev Cancer. 2014;14(2):108\u201319.","journal-title":"Nature Rev Cancer"},{"key":"2532_CR9","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1634\/theoncologist.2012-0410","volume":"18","author":"AJ Lowery","year":"2013","unstructured":"Lowery AJ, Walsh S, McDermott EW, Prichard RS. Molecular and therapeutic advances in the diagnosis and management of malignant pheochromocytomas and paragangliomas. Oncologist. 2013;18:391\u2013407.","journal-title":"Oncologist"},{"key":"2532_CR10","doi-asserted-by":"publisher","first-page":"e8","DOI":"10.3747\/co.21.1579","volume":"21","author":"M Lefebvre","year":"2014","unstructured":"Lefebvre M, Foulkes WD. Pheochromocytoma and paraganglioma syndromes: genetics and management update. Curr Oncol. 2014;21:e8-17.","journal-title":"Curr Oncol"},{"key":"2532_CR11","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1196\/annals.1410.081","volume":"1148","author":"V Kantorovich","year":"2008","unstructured":"Kantorovich V, Eisenhofer G, Pacak K. Pheochromocytoma: an endocrine stress mimicking disorder. Ann N Y Acad Sci. 2008;1148:462\u20138.","journal-title":"Ann N Y Acad Sci"},{"key":"2532_CR12","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s11906-004-0044-2","volume":"6","author":"WM Manger","year":"2004","unstructured":"Manger WM, Eisenhofer G. Pheochromocytoma: diagnosis and management update. Curr Sci Inc. 2004;6:477\u201384.","journal-title":"Curr Sci Inc"},{"issue":"20","key":"2532_CR13","doi-asserted-by":"publisher","first-page":"3974","DOI":"10.1093\/hmg\/ddr324","volume":"20","author":"N Burnichon","year":"2011","unstructured":"Burnichon N, Laure V, Laurence A, Rossella L, de Reynies A, Annabelle V, Elodie J, et al. Integrative genomic analysis reveals somatic mutations in pheochromocytoma and paraganglioma. Hum Mol Genet. 2011;20(20):3974\u201385.","journal-title":"Hum Mol Genet"},{"key":"2532_CR14","doi-asserted-by":"publisher","first-page":"3931","DOI":"10.1073\/pnas.1213394110","volume":"110","author":"A Insinga","year":"2013","unstructured":"Insinga A, Cicalese A, Faretta M, Gallo B, Albano L, Ronzoni S, et al. DNA damage in stem cells activates p21, inhibits p53, and induces symmetric self-renewing divisions. Proc Natl Acad Sci U S A. 2013;110:3931\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2532_CR15","doi-asserted-by":"publisher","first-page":"5443","DOI":"10.1038\/onc.2008.241","volume":"27","author":"Y Yin","year":"2008","unstructured":"Yin Y, Shen WH. PTEN: a new guardian of the genome. Oncogene. 2008;27:5443\u201353.","journal-title":"Oncogene"},{"key":"2532_CR16","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/s41418-018-0246-9","volume":"26","author":"F Mantovani","year":"2019","unstructured":"Mantovani F, Collavin L, Del Sal G. Mutant p53 as a guardian of the cancer cell. Cell Death Differ. 2019;26:199\u2013212.","journal-title":"Cell Death Differ"},{"key":"2532_CR17","doi-asserted-by":"publisher","first-page":"188","DOI":"10.3390\/cancers10060188","volume":"10","author":"R Schulz-Heddergott","year":"2018","unstructured":"Schulz-Heddergott R, Moll UM. Gain-of-function (GOF) mutant p53 as actionable therapeutic target. Cancers (Basel). 2018;10:188.","journal-title":"Cancers (Basel)"},{"key":"2532_CR18","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.semcancer.2011.10.005","volume":"21","author":"L-G Larsson","year":"2011","unstructured":"Larsson L-G. Oncogene- and tumor suppressor gene-mediated suppression of cellular senescence. Semin Cancer Biol. 2011;21:367\u201376.","journal-title":"Semin Cancer Biol"},{"key":"2532_CR19","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.surg.2008.02.007","volume":"143","author":"VE Strong","year":"2008","unstructured":"Strong VE, Kennedy T, Al-Ahmadie H, Tang L, Coleman J, Fong Y, et al. Prognostic indicators of malignancy in adrenal pheochromocytomas: clinical, histopathologic, and cell cycle\/apoptosis gene expression analysis. Surgery. 2008;143:759\u201368.","journal-title":"Surgery"},{"key":"2532_CR20","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1097\/01.ju.0000056085.58221.80","volume":"169","author":"ND Smith","year":"2003","unstructured":"Smith ND, Rubenstein JN, Eggener SE, Kozlowski JM. The p53 tumor suppressor gene and nuclear protein: basic science review and relevance in the management of bladder cancer. J Urol. 2003;169:1219\u201328.","journal-title":"J Urol"},{"key":"2532_CR21","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1038\/nrd4145","volume":"12","author":"L Galluzzi","year":"2013","unstructured":"Galluzzi L, Kepp O, Vander Heiden MG, Kroemer G. Metabolic targets for cancer therapy. Nat Rev Drug Discov. 2013;12:829\u201346.","journal-title":"Nat Rev Drug Discov"},{"key":"2532_CR22","doi-asserted-by":"publisher","first-page":"68","DOI":"10.5114\/wo.2014.47136","volume":"1A","author":"K Tomczak","year":"2015","unstructured":"Tomczak K, Czerwi\u0144ska P, Wiznerowicz M. Review the cancer genome atlas (TCGA): an immeasurable source of knowledge. Wsp\u00f3\u0142czesna Onkologia. 2015;1A:68\u201377.","journal-title":"Wsp\u00f3\u0142czesna Onkologia"},{"key":"2532_CR23","unstructured":"NIH. About the GDC | NCI Genomic Data Commons [Internet]. [cited 2024 Aug 6]. Available from: https:\/\/gdc.cancer.gov\/about-gdc"},{"key":"2532_CR24","doi-asserted-by":"crossref","unstructured":"Cancer Genome Atlas Research Network, Weinstein JN, Collisson EA, Mills GB, Shaw KRM, Ozenberger BA, et al. The Cancer Genome Atlas Pan-Cancer analysis project. Nat Genet. 2013;45:1113\u201320.","DOI":"10.1038\/ng.2764"},{"key":"2532_CR25","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.ygeno.2017.01.005","volume":"109","author":"Y Guo","year":"2017","unstructured":"Guo Y, Dai Y, Yu H, Zhao S, Samuels DC, Shyr Y. Improvements and impacts of GRCh38 human reference on high throughput sequencing data analysis. Genomics. 2017;109:83\u201390.","journal-title":"Genomics"},{"key":"2532_CR26","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1101\/gr.107524.110","volume":"20","author":"A McKenna","year":"2010","unstructured":"McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A, et al. The genome analysis toolkit: a mapreduce framework for analyzing next-generation DNA sequencing data. Genome Res. 2010;20:1297\u2013303.","journal-title":"Genome Res"},{"key":"2532_CR27","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1016\/j.jmoldx.2022.08.006","volume":"24","author":"KE Craven","year":"2022","unstructured":"Craven KE, Fischer CG, Jiang L, Pallavajjala A, Lin M-T, Eshleman JR. Optimizing insertion and deletion detection using next-generation sequencing in the clinical laboratory. J Mol Diagn. 2022;24:1217\u201331.","journal-title":"J Mol Diagn"},{"key":"2532_CR28","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/nbt.2514","volume":"31","author":"K Cibulskis","year":"2013","unstructured":"Cibulskis K, Lawrence MS, Carter SL, Sivachenko A, Jaffe D, Sougnez C, et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol. 2013;31:213\u20139.","journal-title":"Nat Biotechnol"},{"key":"2532_CR29","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkq603","volume":"38","author":"K Wang","year":"2010","unstructured":"Wang K, Li M, Hakonarson H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 2010;38: e164.","journal-title":"Nucleic Acids Res"},{"key":"2532_CR30","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s13059-016-0974-4","volume":"17","author":"W McLaren","year":"2016","unstructured":"McLaren W, Gil L, Hunt SE, Riat HS, Ritchie GRS, Thormann A, et al. The ensemble variant effect predictor. Genome Biol. 2016;17:122.","journal-title":"Genome Biol"},{"key":"2532_CR31","doi-asserted-by":"publisher","first-page":"3812","DOI":"10.1093\/nar\/gkg509","volume":"31","author":"PC Ng","year":"2003","unstructured":"Ng PC. SIFT: predicting amino acid changes that affect protein function. Nucleic Acids Res. 2003;31:3812\u20134.","journal-title":"Nucleic Acids Res"},{"key":"2532_CR32","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1089\/gtmb.2010.0036","volume":"14","author":"SE Flanagan","year":"2010","unstructured":"Flanagan SE, Patch A-M, Ellard S. Using SIFT and PolyPhen to predict loss-of-function and gain-of-function mutations. Genet Test Mol Biomarkers. 2010;14:533\u20137.","journal-title":"Genet Test Mol Biomarkers"},{"key":"2532_CR33","doi-asserted-by":"publisher","first-page":"69","DOI":"10.58496\/BJML\/2024\/007","volume":"2024","author":"HA Salman","year":"2024","unstructured":"Salman HA, Kalakech A, Steiti A. Random forest algorithm overview. Babylon J Mach Learn. 2024;2024:69\u201379.","journal-title":"Babylon J Mach Learn"},{"key":"2532_CR34","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.ccell.2017.01.001","volume":"31","author":"L Fishbein","year":"2017","unstructured":"Fishbein L, Leshchiner I, Walter V, Danilova L, Robertson AG, Johnson AR, et al. Comprehensive molecular characterization of pheochromocytoma and paraganglioma. Cancer Cell. 2017;31:181\u201393.","journal-title":"Cancer Cell"},{"key":"2532_CR35","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1007\/s12094-021-02622-9","volume":"23","author":"R Garcia-Carbonero","year":"2021","unstructured":"Garcia-Carbonero R, Matute Teresa F, Mercader-Cidoncha E, Mitjavila-Casanovas M, Robledo M, Tena I, et al. Multidisciplinary practice guidelines for the diagnosis, genetic counseling and treatment of pheochromocytomas and paragangliomas. Clin Transl Oncol. 2021;23:1995\u20132019.","journal-title":"Clin Transl Oncol"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-024-02532-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-024-02532-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-024-02532-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T09:33:31Z","timestamp":1763631211000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12032-024-02532-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,17]]},"references-count":35,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2024,11]]}},"alternative-id":["2532"],"URL":"https:\/\/doi.org\/10.1007\/s12032-024-02532-0","relation":{},"ISSN":["1559-131X"],"issn-type":[{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,17]]},"assertion":[{"value":"29 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2025","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised: The University name in the 4th affiliation \"Laboratory Medicine Department, Faculty of Applied Medical Sciences, Albaha University, Albaha 65431, Saudi Arabia\" should read \"Al-Baha University\" instead of \"Albaha University\". It is now corrected.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"290"}}